Accuracies of Serum and Fecal S100 Proteins (Calprotectin and Calgranulin C) to Predict the Response to TNF Antagonists in Patients with Crohnʼs Disease-Reference-Cited by-同舟云学术

Accuracies of Serum and Fecal S100 Proteins (Calprotectin and Calgranulin C) to Predict the Response to TNF Antagonists in Patients with Crohnʼs Disease

Published:2015-02 Issue:2 Volume:21 Page:331-336
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:Inflammatory Bowel Diseases

Author:

Boschetti Gilles,Garnero Patrick,Moussata Driffa,Cuerq Charlotte,Préaudat Corinne,Duclaux-Loras Remi,Mialon Anne,Drai Jocelyne,Flourié Bernard,Nancey Stephane

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Reference19 articles.

1. Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome

2. Fecal S100A12: A novel noninvasive marker in children with Crohnʼs disease

3. Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children

4. Neopterin Is a Novel Reliable Fecal Marker as Accurate as Calprotectin for Predicting Endoscopic Disease Activity in Patients with Inflammatory Bowel Diseases

5. Crohnʼs disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohnʼs disease activity index and endoscopic findings

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision Medicine in Inflammatory Bowel Disease: A Spotlight on Emerging Molecular Biomarkers;Biomedicines;2024-07-08

2. Establishing a pediatric reference interval for plasma calprotectin;Scandinavian Journal of Clinical and Laboratory Investigation;2024-04

3. Recent Trends in Non-Invasive Methods of Diagnosis and Evaluation of Inflammatory Bowel Disease: A Short Review;International Journal of Molecular Sciences;2024-02-08

4. Circulating Profiles of Serum Proguanylin, S100A12 Protein and Pentraxin 3 as Diagnostic Markers of Ulcerative Colitis;Journal of Clinical Medicine;2023-06-28

5. Monitoring of patients with active inflammatory bowel disease;Frontiers in Gastroenterology;2023-05-25